Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
86.60    2.60 (3.10%)
Bid:
86.80
Ask:
87.60
Spread: 0.80 (0.922%)
Market Cap: £242.66m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

2026 AGM Trading Update

20 May 2026 07:00

RNS Number : 9824E
Essentra plc
20 May 2026
 

Essentra PLC

("Essentra", the "Group" or the "Company")

AGM Trading Update

Trading in line, FY26 expectations unchanged

 

Essentra plc, a leading global provider and manufacturer of essential components and solutions, provides a trading update for the four months ended 2 May 2026 (the "period"), ahead of its Annual General Meeting, to be held at 13:00 BST today.

 

Trading update

Despite the volatile macroeconomic backdrop, the Group traded in line with the Board's expectations during the first four months of 2026. Order intake momentum was maintained and is ahead of sales, supported by a disciplined approach to pricing and a continued focus on faster-growth end-markets.

Group revenue increased by 7.2%, on a constant currency, trading day adjusted basis compared to the same period in 2025. Like-for-like1 sales increased by 5.2%, reflecting a combination of pricing and volume, alongside 2.0% inorganic growth from the acquisition of Device Technologies which completed in December 2025.

Regional performance in the period was mixed. On a like-for-like, day adjusted basis, EMEA delivered high-single digit growth driven by both volume and pricing, including some early, albeit modest, indications of recovery across West Europe and continued strength in Turkey. The Americas delivered low single-digit growth in the period primarily reflecting ongoing pricing actions. APAC trading was broadly flat compared to the prior year.

Across all three regions, fastergrowth endmarkets, including digital infrastructure and energy transformation continue to offset modest softness in traditional core markets such as automotive.

The business remains focused on operating efficiency initiatives, including automation investments and rigorous cost control, supporting Group margin.

The Group's direct exposure to the Middle East is limited and there was no material direct impact on trading in the period. Essentra remains well-positioned with a diversified customer base, in‑region manufacturing and localised supply chains. The Group also retains pricing agility with management implementing a further round of pricing actions across all regions in Q2 to help mitigate inflationary pressures.

The balance sheet remains robust. Net debt leverage at the half year is expected to be c1.6x following the agreement to acquire Boteco, an expert designer and manufacturer of mechanical components, for an initial cash consideration of €7.4m, announced separately today. Boteco is expected to be accretive to Group margins and adjusted EPS in the first full year post-completion.

 

Outlook

The Board's FY26 expectations remain unchanged. While mindful of ongoing geopolitical events the Group remains well-positioned, benefitting from agile supply chains and operational capacity. Essentra will continue to focus on enhancing its customer proposition in faster‑growing end‑markets whilst also remaining focused on margin-enhancing activities and shareholder value creation through business simplification and a segmented customer approach. This will position the Group well to deliver further growth and strategic progress towards its medium-term targets during 2026.

 

 

 

 

Enquiries

Essentra plc

Rowan Baker, Chief Financial Officer

Claire Goodman, Head of Investor Relations

investorrelations@essentra.com

Tel: +44 (0)1908 359100

FTI Consulting

Richard Mountain

Ariadna Peretz

FTI_essentra@fticonsulting.com

Tel: +44 (0)20 3727 1340

Notes:

1. Like-for-like ("LFL") excludes the impact of Device Technologies acquisition and foreign exchange

 

Notes to Editors

About Essentra plc

Essentra plc is a leading global provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items. Headquartered in the United Kingdom, Essentra's global network extends to 28 countries worldwide and includes c.3,000 employees, 14 manufacturing facilities, 25 distribution centres and 35 sales & service centres serving c.76,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy. For further information, please visit www.essentraplc.com

LEI: 5493007MOZNA03BVNE96

Cautionary forward-looking statement

These results contain forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. The Company accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events or developments, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDKLFFQELBBBV
Date   Source Headline
10th Jun 20269:47 amRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:32 pmRNSTransaction in Own Shares
21st May 202610:55 amRNSResult of AGM
20th May 20267:00 amRNSAcquisition of Boteco Srl
20th May 20267:00 amRNS2026 AGM Trading Update
14th May 20265:15 pmRNSDirector/PDMR Shareholding
12th May 20267:03 amRNSTransaction in Own Shares
1st May 202612:17 pmRNSTotal Voting Rights
29th Apr 20268:12 amRNSTransaction in Own Shares
28th Apr 20263:25 pmRNSDirector/PDMR Shareholding
24th Apr 20263:30 pmRNSDirector/PDMR Shareholding
22nd Apr 20268:15 amRNSTransaction in Own Shares
21st Apr 20264:09 pmRNSDirector/PDMR Shareholding
17th Apr 20267:52 amRNSHolding(s) in Company
15th Apr 202610:06 amRNSDirector/PDMR Shareholding
15th Apr 20268:24 amRNSTransaction in Own Shares
15th Apr 20268:18 amRNSHolding(s) in Company
9th Apr 20268:24 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSHolding(s) in Company
1st Apr 20264:45 pmRNSDirector/PDMR Shareholding
1st Apr 20263:21 pmRNSDirector/PDMR Shareholding
1st Apr 20263:15 pmRNSTransaction in Own Shares
1st Apr 20263:08 pmRNSTotal Voting Rights
30th Mar 20262:00 pmRNSAnnual Financial Report
24th Mar 202610:05 amRNSTransaction in Own Shares
24th Mar 20268:17 amRNSHolding(s) in Company
19th Mar 20268:43 amRNSDirector/PDMR Shareholding
17th Mar 20261:41 pmRNSDirector/PDMR Shareholding
17th Mar 202610:30 amRNSDirectorate change
17th Mar 202610:28 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
16th Mar 20269:40 amRNSTransaction in Own Shares
16th Mar 20269:40 amRNSTransaction in Own Shares
13th Mar 202612:00 pmRNSCompany Secretary Change
9th Mar 20269:00 amRNSNotice of Full Year 2025 Results
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:58 amRNSHolding(s) in Company
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202612:20 pmRNSHolding(s) in Company
17th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.